logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Pharmaceutical Intermediates > 2-Cyanophenylboronic Acid-1,3-propanediol Ester CAS 172732-52-4

2-Cyanophenylboronic Acid-1,3-propanediol Ester CAS 172732-52-4

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 172732-52-4

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
172732-52-4
Appearance::
White Solid
Molecular Formula::
C10H10BNO2
Molecular Weight::
187.00300
EINECS NO::
691-968-9
MDL NO::
MFCD04039012
CAS NO::
172732-52-4
Appearance::
White Solid
Molecular Formula::
C10H10BNO2
Molecular Weight::
187.00300
EINECS NO::
691-968-9
MDL NO::
MFCD04039012
2-Cyanophenylboronic Acid-1,3-propanediol Ester CAS 172732-52-4

Product Description:

Product Name: 2-Cyanophenylboronic acid-1,3-propanediol ester CAS NO: 172732-52-4

 

 

Synonyms:

2-(1,3,2-Dioxaborinan-2-yl)benzonitrile;

2-Cyanophenylboronic acid,1,3-propanediol cyclic ester;

2-Cyanophenylboronic Acid 1,3-Propanediol Ester;

 

 

Chemical & Physical Properties:

Appearance: White solid

Assay :≥99.0%

Density: 1.13g/cm3

Boiling Point: 372.4℃ at 760 mmHg

Melting Point: 46-56℃ (lit.)

Flash Point: 179℃

Refractive Index: 1.519

Vapor Pressure: 9.63E-06mmHg at 25℃

 

 

Safety Information:

Hazard Code: Xi

HS Code: 2934999090

RIDADR: UN 3439

Risk Statements: R20/21/22

Safety Statements: S26; S36/37/39

 

 

2-(2-Cyanophenyl)-1,3,2-dioxaborinane is used in the synthesis of AMPA receptor antagonists in the treatment of neurological diseases causing dysfunction of glutamatergic neurotransmission. Also used in the small scale synthesis of Perampanel, an AMPA receptor antagonist.

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.